
Heart Failure Detection Study
Clinical trial evaluating the validity of a current blood test in the diagnosis of heart failure in adults
Qualified participants will undergo a single blood draw.
Our physicians at Eastside Research Associates have partnered with a sponsor to evaluate the validity of the American Heart Association's current guidelines for B-type natriuretic peptide (BNP) blood levels as an indicator of heart failure.
​
A B-type natriuretic peptide (BNP) test gives your provider information about how your heart is working. This blood test measures the levels of a protein called BNP in your bloodstream. When your heart has to work harder to pump blood, it makes more BNP. Higher levels of BNP can be a sign of heart failure.
​
The study will involve a single blood draw and the entire appointment will last approximately 45 - 60 minutes.
​
Participants enrolled in this new clinical research study will be compensated for their time.
Participant Enrollment Criteria
-
18 years of age or older
-
New onset or worsening heart failure Symptoms include:
-
Shortness of breath
-
Lower leg edema (swelling)
-
Fatigue
-
Palpitations
-
Unable to carry out any physical activity without discomfort
-
-
Additional criteria apply
Participants Will Receive
-
Compensation for their time and effort
Location and Time
-
Eastside Research Associates Midland, TX clinic
-
One visit lasting 45-60 minutes